HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ming Yao Selected Research

2,2-dimethylpropionic acid 3- (2- chloro- 6- methylaminopurin- 9- yl)- 2- (2,2- dimethylpropionyloxymethyl)propyl ester

1/2017P2Y12 receptor-mediated activation of spinal microglia and p38MAPK pathway contribute to cancer-induced bone pain.
8/2014[Effects of intrathecal injection P2Y12 receptor inhibitor on interleukin-1 beta and interleukin-6 in spinal cord of rat bone cancer pain model].
10/2012[Influence of P2Y12 receptor inhibitor on pain threshold and spinal p38MAPK in rat bone cancer pain model].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ming Yao Research Topics

Disease

152Neoplasms (Cancer)
01/2022 - 01/2002
70Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2002
61Neoplasm Metastasis (Metastasis)
10/2022 - 08/2002
37Pain (Aches)
09/2022 - 05/2006
22Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2021 - 03/2006
15Hyperalgesia
01/2022 - 08/2014
14Infections
05/2022 - 06/2010
14Carcinogenesis
01/2022 - 08/2010
14Lung Neoplasms (Lung Cancer)
11/2020 - 06/2003
12Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2022 - 05/2014
11Inflammation (Inflammations)
01/2022 - 02/2015
11Breast Neoplasms (Breast Cancer)
01/2022 - 01/2011
11Bone Neoplasms (Bone Cancer)
01/2021 - 07/2011
10Neuralgia (Stump Neuralgia)
05/2022 - 11/2011
9Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 01/2015
8Postherpetic Neuralgia
09/2022 - 01/2020
8Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2021 - 09/2007
7Herpes Zoster
01/2022 - 01/2020
7Ischemic Stroke
12/2021 - 10/2011
7Adenocarcinoma of Lung
11/2020 - 06/2005
7Disease Progression
01/2020 - 07/2005
7Liver Neoplasms (Liver Cancer)
11/2019 - 11/2013
6Lymphoma (Lymphomas)
12/2021 - 06/2014
6Carcinoma (Carcinomatosis)
01/2015 - 06/2003
5Multiple Myeloma
03/2022 - 09/2003
5Hyperhidrosis
01/2022 - 10/2011
5Stroke (Strokes)
01/2022 - 01/2002
5Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 04/2014
5Hypoxia (Hypoxemia)
01/2021 - 12/2011
5Trigeminal Neuralgia (Tic Douloureux)
01/2021 - 08/2014
5Ovarian Neoplasms (Ovarian Cancer)
10/2019 - 09/2002
5Leukemia
02/2019 - 05/2009
4Hypersensitivity (Allergy)
05/2022 - 11/2011
4COVID-19
03/2022 - 11/2020
4Hematologic Neoplasms (Hematological Malignancy)
03/2022 - 05/2011
4Burns
01/2021 - 12/2013
4Stomach Neoplasms (Stomach Cancer)
03/2020 - 08/2002
4Glioma (Gliomas)
01/2019 - 04/2010
4Diabetes Mellitus
01/2018 - 02/2014
4Hepatitis B
01/2018 - 06/2014

Drug/Important Bio-Agent (IBA)

46Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2002
20Biological ProductsIBA
01/2022 - 03/2002
19MicroRNAs (MicroRNA)IBA
01/2021 - 03/2010
17Pharmaceutical PreparationsIBA
05/2022 - 06/2005
16Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2011
13ErbB Receptors (EGF Receptor)IBA
01/2020 - 01/2002
12Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 12/2003
10Messenger RNA (mRNA)IBA
01/2021 - 04/2010
10CytokinesIBA
01/2019 - 07/2003
9Long Noncoding RNAIBA
10/2022 - 01/2017
9Interleukin-6 (Interleukin 6)IBA
01/2022 - 11/2011
9DNA (Deoxyribonucleic Acid)IBA
01/2019 - 01/2002
8Small Interfering RNA (siRNA)IBA
01/2022 - 06/2005
8Cisplatin (Platino)FDA LinkGeneric
01/2020 - 11/2005
7Sorafenib (BAY 43-9006)FDA Link
01/2022 - 06/2012
7Analgesics (Analgesic Drugs)IBA
01/2022 - 05/2006
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2017 - 11/2005
6C-Reactive ProteinIBA
05/2022 - 05/2011
6Epidermal Growth Factor (EGF)IBA
12/2021 - 01/2002
6LigandsIBA
01/2021 - 07/2003
6RNA (Ribonucleic Acid)IBA
12/2020 - 08/2005
5Therapeutic UsesIBA
01/2022 - 02/2018
5Glucose (Dextrose)FDA LinkGeneric
12/2021 - 09/2013
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2021 - 11/2005
5Antineoplastic Agents (Antineoplastics)IBA
01/2021 - 10/2010
5Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2021 - 04/2010
5Carrier Proteins (Binding Protein)IBA
01/2019 - 02/2014
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2018 - 09/2002
5Phosphotransferases (Kinase)IBA
01/2018 - 10/2010
5Transcription Factors (Transcription Factor)IBA
11/2017 - 12/2014
5isocorydineIBA
02/2017 - 01/2012
5Adenosine Triphosphate (ATP)IBA
04/2016 - 12/2008
5Monoclonal AntibodiesIBA
02/2014 - 07/2003
4Rituximab (Mabthera)FDA Link
02/2022 - 06/2014
4NF-kappa B (NF-kB)IBA
10/2021 - 06/2010
4UbiquitinIBA
01/2021 - 04/2010
4CateninsIBA
01/2021 - 01/2016
4Oxygen (Dioxygen)IBA
01/2021 - 12/2013
4EnzymesIBA
06/2020 - 11/2013
4ParaffinIBA
12/2019 - 11/2005
4p38 Mitogen-Activated Protein KinasesIBA
01/2019 - 01/2016
4Indicators and Reagents (Reagents)IBA
01/2019 - 11/2010
4Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2019 - 06/2014
4Antiviral Agents (Antivirals)IBA
01/2018 - 06/2014
4SolutionsIBA
01/2016 - 04/2008

Therapy/Procedure

48Therapeutics
12/2021 - 09/2002
19Drug Therapy (Chemotherapy)
12/2021 - 01/2004
11Hematopoietic Stem Cell Transplantation
11/2022 - 09/2007
9Transplantation
02/2022 - 09/2007
8Electrocoagulation (Electrocautery)
09/2022 - 08/2014
8Punctures
01/2022 - 10/2011
7Analgesia
09/2022 - 10/2012
6Aftercare (After-Treatment)
09/2022 - 11/2018
5Spinal Injections
01/2022 - 10/2012
5Radiofrequency Ablation
10/2021 - 01/2019
5Radiotherapy
05/2021 - 01/2004
5Induction Chemotherapy
01/2021 - 04/2007
4Sympathectomy (Sympathectomies)
01/2022 - 01/2021
4Stem Cell Transplantation
01/2022 - 11/2018
4Immunotherapy
01/2021 - 11/2018